Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients
Yu Feng, Le Tang, Hongyu Wang, Yutao Liu, Sheng Yang, Lin Lin, Xingsheng Hu, Yuankai Shi
Topics & Concepts
MedicineInternal medicineAdenocarcinomaGastroenterologyClinical endpointLung cancerBevacizumabAdverse effectOncologyApatinibProgression-free survivalSurgeryChemotherapyCancerClinical trialLung Cancer Research StudiesCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment